Celsee Diagnostics

Plymouth, United States Founded: 2011 • Age: 15 yrs Acquired By Bio Rad
Liquid biopsy technology for monitoring circulating tumor cells is provided.
Request Access

About Celsee Diagnostics

Celsee Diagnostics is a company based in Plymouth (United States) founded in 2011 was acquired by Bio Rad in April 2020.. Celsee Diagnostics has raised $40.43 million across 14 funding rounds from investors including Bio Rad and Ann Arbor SPARK. The company has 18 employees as of December 31, 2017. Celsee Diagnostics operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.

  • Headquarter Plymouth, United States
  • Employees 18 as on 31 Dec, 2017
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $40.43 M (USD)

    in 14 rounds

  • Latest Funding Round
    $5.11 M (USD), Series B

    Dec 20, 2019

  • Investors
    Bio Rad

    & 1 more

  • Employee Count
    18

    as on Dec 31, 2017

  • Acquired by
    Bio Rad

    (Apr 09, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Celsee Diagnostics

Celsee Diagnostics has successfully raised a total of $40.43M across 14 strategic funding rounds. The most recent funding activity was a Series B round of $5.11 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 14
  • Last Round Series B — $5.1M
  • First Round

    (20 Jul 2011)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2019 Amount Series B - Celsee Diagnostics Valuation

investors

Nov, 2018 Amount Series B - Celsee Diagnostics Valuation

investors

May, 2018 Amount Debt – Conventional - Celsee Diagnostics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Celsee Diagnostics

Celsee Diagnostics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Bio Rad and Ann Arbor SPARK. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Portfolio of products and services for life science research and clinical diagnostic markets
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Celsee Diagnostics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Celsee Diagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Celsee Diagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Celsee Diagnostics

Celsee Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Digital sequencing technology for cancer detection is developed.
domain founded_year HQ Location
Circulating tumor DNA is screened for early cancer detection.
domain founded_year HQ Location
Developer of cell-free DNA testing for oncology, women’s health, and organ health
domain founded_year HQ Location
Genomics-based diagnostic tests for cancer are provided.
domain founded_year HQ Location
Molecular cancer diagnostic products are developed using patented AMP technology.
domain founded_year HQ Location
Health risks are identified through online genetic and diagnostic testing.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Celsee Diagnostics

Frequently Asked Questions about Celsee Diagnostics

When was Celsee Diagnostics founded?

Celsee Diagnostics was founded in 2011.

Where is Celsee Diagnostics located?

Celsee Diagnostics is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.

Is Celsee Diagnostics a funded company?

Celsee Diagnostics is a funded company, having raised a total of $40.43M across 14 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $2.39M, raised on Jul 20, 2011.

How many employees does Celsee Diagnostics have?

As of Dec 31, 2017, the latest employee count at Celsee Diagnostics is 18.

What does Celsee Diagnostics do?

Founded in 2011 and based in Plymouth, United States, Celsee Diagnostics operates in the biotechnology sector. An instrument system and reagent kit are offered by the company for the separation, detection, and retrieval of circulating tumor cells from peripheral whole blood. This approach serves as an alternative to invasive biopsies, utilizing microfluidic chips to capture rare cancer cells and support downstream molecular analysis for research purposes.

Who are the top competitors of Celsee Diagnostics?

Celsee Diagnostics's top competitors include Guardant Health, GRAIL and Foundation Medicine.

Who are Celsee Diagnostics's investors?

Celsee Diagnostics has 2 investors. Key investors include Bio Rad, and Ann Arbor SPARK.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available